{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:15:31Z","timestamp":1761765331878},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T00:00:00Z","timestamp":1285027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T00:00:00Z","timestamp":1285027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00431-010-1294-4","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T08:01:19Z","timestamp":1284969679000},"page":"339-345","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children"],"prefix":"10.1007","volume":"170","author":[{"given":"Jeanet M.","family":"Kemmeren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline A. T.","family":"van der Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,21]]},"reference":[{"key":"1294_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1086\/646687","volume":"14","author":"LK Ammari","year":"1993","unstructured":"Ammari LK, Bell LM, Hodinka RL (1993) Secondary measles vaccine failure in healthcare workers exposed to infected patients. Infect Control Hosp Epidemiol 14:81\u201386","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1294_CR2","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/S0264-410X(98)00426-5","volume":"17","author":"FE Andre","year":"1999","unstructured":"Andre FE (1999) Development and clinical application of new polyvalent combined paediatric vaccines. Vaccine 17:1620\u201316276","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"1294_CR3","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","volume":"20","author":"NW Baylor","year":"2002","unstructured":"Baylor NW, Egan W, Richman P (2002) Aluminum salts in vaccines\u2013US perspective. Vaccine 20(Suppl 3):S18\u2013S23","journal-title":"Vaccine"},{"key":"1294_CR4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/00006454-199809000-00011","volume":"17","author":"PC Begue","year":"1998","unstructured":"Begue PC, Grimprel EM, Giovannangeli MD, Abitbol VI (1998) Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents. Pediatr Infect Dis J 17:804\u2013809","journal-title":"Pediatr Infect Dis J"},{"key":"1294_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","volume":"55","author":"C Black","year":"2003","unstructured":"Black C, Kaye JA, Jick H (2003) MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol 55:107\u2013111","journal-title":"Br J Clin Pharmacol"},{"key":"1294_CR6","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1016\/j.vaccine.2006.04.001","volume":"24","author":"S Black","year":"2006","unstructured":"Black S, Friedland LR, Schuind A, Howe B (2006) Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4\u20136\u00a0years. Vaccine 24:6163\u20136171","journal-title":"Vaccine"},{"key":"1294_CR7","first-page":"S30","volume":"9","author":"H Bogaerts","year":"2003","unstructured":"Bogaerts H (2003) The future of childhood immunizations: examining the European experience. Am J Manag Care 9:S30\u2013S36","journal-title":"Am J Manag Care"},{"key":"1294_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/bmj.39541.534109.BE","volume":"336","author":"L Brabin","year":"2008","unstructured":"Brabin L, Roberts SA, Stretch R et al (2008) Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 336:1056\u20131058","journal-title":"BMJ"},{"key":"1294_CR9","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1016\/j.vaccine.2007.05.017","volume":"25","author":"M Bults","year":"2007","unstructured":"Bults M, Kemmeren JM, van der Maas NA (2007) Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands. Vaccine 25:5272\u20135277","journal-title":"Vaccine"},{"key":"1294_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.aje.a115106","volume":"129","author":"RT Chen","year":"1989","unstructured":"Chen RT, Goldbaum GM, Wassilak SG et al (1989) An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol 129:173\u2013182","journal-title":"Am J Epidemiol"},{"issue":"Suppl 3","key":"1294_CR11","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S0264-410X(02)00168-8","volume":"20","author":"CJ Clements","year":"2002","unstructured":"Clements CJ, Griffiths E (2002) The global impact of vaccines containing aluminium adjuvants. Vaccine 20(Suppl 3):S24\u2013S33","journal-title":"Vaccine"},{"key":"1294_CR12","first-page":"277","volume-title":"Vaccines","author":"S Cochi","year":"1994","unstructured":"Cochi S, Wharton M, Plotkin S (1994) Mumps vaccine. In: Plotkin SA, Mortimer EAJ (eds) Vaccines. WB Saunders, Philadelphia, pp 277\u2013301"},{"key":"1294_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1542\/peds.100.5.767","volume":"100","author":"RL Davis","year":"1997","unstructured":"Davis RL, Marcuse E, Black S et al (1997) MMR2 immunisation at 4 to 5\u00a0years and 10 to 12\u00a0years of age: a comparison of adverse clinical events after immunisation in the Vaccine Safety Datalink Project. Pediatrics 100:767\u2013771","journal-title":"Pediatrics"},{"key":"1294_CR14","first-page":"S6","volume":"9","author":"D Dodd","year":"2003","unstructured":"Dodd D (2003) Benefits of combination vaccines: effective vaccination on a simplified schedule. Am J Manag Care 9:S6\u2013S12","journal-title":"Am J Manag Care"},{"key":"1294_CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5694\/j.1326-5377.2003.tb05497.x","volume":"179","author":"MS Gold","year":"2003","unstructured":"Gold MS, Noonan S, Osbourn M et al (2003) Local reactions after the fourth dose of acellular pertussis vaccine in South Australia. Med J Aust 179:191\u2013194","journal-title":"Med J Aust"},{"key":"1294_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/00365540110026593","volume":"33","author":"L Gothefors","year":"2001","unstructured":"Gothefors L, Bergstrom E, Backman M (2001) Immunogenicity and reactogenicity of a new measles, mumps and rubella vaccine when administered as a second dose at 12\u00a0years of age. Scand J Infect Dis 33:545\u2013549","journal-title":"Scand J Infect Dis"},{"key":"1294_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amepre.2006.03.017","volume":"31","author":"DA Gust","year":"2006","unstructured":"Gust DA, Campbell S, Kennedy A et al (2006) Parental concerns and medical-seeking behavior after immunization. Am J Prev Med 31:32\u201335","journal-title":"Am J Prev Med"},{"issue":"3","key":"1294_CR18","first-page":"49","volume":"334","author":"L Gustaffson","year":"1996","unstructured":"Gustaffson L, Hallander HO, Olin P et al (1996) A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334(3):49\u2013355","journal-title":"N Engl J Med"},{"key":"1294_CR19","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/S0264-410X(03)00173-7","volume":"21","author":"SA Halperin","year":"2003","unstructured":"Halperin SA, Scheifele D, Mills E et al (2003) Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine. Vaccine 21:2298\u20132306","journal-title":"Vaccine"},{"key":"1294_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jadohealth.2005.08.009","volume":"37","author":"LM Huang","year":"2005","unstructured":"Huang LM, Chang LY, Tang H et al (2005) Immunigenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents. J Adolesc Health 37:517","journal-title":"J Adolesc Health"},{"key":"1294_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1473-3099(04)00927-2","volume":"4","author":"T Jefferson","year":"2004","unstructured":"Jefferson T, Rudin M, Di Pietrantonj C (2004) Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. Lancet Infect Dis 4:84\u201390","journal-title":"Lancet Infect Dis"},{"key":"1294_CR22","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1542\/peds.2006-0678","volume":"118","author":"CW LeBaron","year":"2006","unstructured":"LeBaron CW, Daoling BI, Sullivan BJ et al (2006) Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine. Pediatrics 118:1422\u20131430","journal-title":"Pediatrics"},{"key":"1294_CR23","unstructured":"Maas van der NAT, Zonnenberg-Hoff IF, David S, et al (2008) Adverse events following immunisation under the national vaccination programme of The Netherlands. Number XIV\u2014Reports in 2007. National Institute for Public Health and Environment, Bilthoven"},{"key":"1294_CR24","first-page":"229","volume-title":"Vaccines","author":"L Markowitz","year":"1994","unstructured":"Markowitz L, Katz S (1994) Measles vaccine. In: Plotkin SA, Mortimer EAJ (eds) Vaccines. WB Saunders, Philadelphia, pp 229\u2013276"},{"key":"1294_CR25","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1016\/j.vaccine.2006.05.017","volume":"24","author":"H Marshall","year":"2006","unstructured":"Marshall H, Nolan T, Roberton D et al (2006) A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4\u20136\u00a0years. Vaccine 24:6120\u20136128","journal-title":"Vaccine"},{"key":"1294_CR26","volume-title":"The national immunisation programme in the Netherlands","author":"H de Melker","year":"2007","unstructured":"de Melker H, Gerritsen A, Hahn\u00e9 S (2007) The national immunisation programme in the Netherlands. RIVM, Bilthoven"},{"key":"1294_CR27","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1016\/S0264-410X(01)00123-2","volume":"19","author":"E Miller","year":"2001","unstructured":"Miller E, Waight P, Laurichesse H et al (2001) Immunogenicity and reactogenicity of acellular diphtheria\/tetanus\/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR. Vaccine 19:3904\u20133911","journal-title":"Vaccine"},{"key":"1294_CR28","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","volume":"350","author":"P Olin","year":"1997","unstructured":"Olin P, Rasmussen F, Gustaffson L et al (1997) Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compard with whole-cell pertussis vaccine. Lancet 350:1569\u20131577","journal-title":"Lancet"},{"key":"1294_CR29","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/00365540310015719","volume":"35","author":"PA Parment","year":"2003","unstructured":"Parment PA, Svahn A, Ruden U et al (2003) Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12\u00a0years of age. Scand J Infect Dis 35:736\u2013742","journal-title":"Scand J Infect Dis"},{"key":"1294_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(86)91044-5","volume":"1","author":"H Peltola","year":"1986","unstructured":"Peltola H, Heinonen OP (1986) Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet 1:939\u2013942","journal-title":"Lancet"},{"key":"1294_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00006454-200203000-00018","volume":"21","author":"MB Rennels","year":"2002","unstructured":"Rennels MB (2002) Combination vaccines. Pediatr Infect Dis J 21:255\u2013257","journal-title":"Pediatr Infect Dis J"},{"key":"1294_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1045-1870(03)00033-5","volume":"14","author":"MB Rennels","year":"2003","unstructured":"Rennels MB (2003) Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin Pediatr Infect Dis 14:196\u2013198","journal-title":"Semin Pediatr Infect Dis"},{"key":"1294_CR33","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00431-006-0403-x","volume":"166","author":"R Sanger","year":"2007","unstructured":"Sanger R, Behre U, Krause KH et al (2007) Booster vaccination and 1-year follow-up of 4\u20138\u00a0year old children with a reduced-antigen-content dTpa-IPV vaccine. Eur J Pediatr 166:1229\u20131236","journal-title":"Eur J Pediatr"},{"key":"1294_CR34","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1016\/S0264-410X(01)00230-4","volume":"19","author":"DW Scheifele","year":"2001","unstructured":"Scheifele DW, Halperin SA, Ferguson AC (2001) Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens. Vaccine 19:4720\u20134726","journal-title":"Vaccine"},{"key":"1294_CR35","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/01.inf.0000190028.96152.46","volume":"24","author":"DW Scheifele","year":"2005","unstructured":"Scheifele DW, Halperin SA, Ochnio JJ et al (2005) A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial. Pediatr Infect Dis J 24:1059\u20131066","journal-title":"Pediatr Infect Dis J"},{"key":"1294_CR36","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1542\/peds.106.5.e62","volume":"106","author":"M Virtanen","year":"2000","unstructured":"Virtanen M, Peltola H, Paunio M, Heinonen OP (2000) Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics 106:e62","journal-title":"Pediatrics"},{"key":"1294_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2431-9-18","volume":"5","author":"F Wei","year":"2009","unstructured":"Wei F, Mullooly JP, Goodman M et al (2009) Identification and characteristics of vaccine refusers. BMC Pediatr 5:18","journal-title":"BMC Pediatr"},{"key":"1294_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4161\/hv.6.3.10503","volume":"6","author":"F Zhu","year":"2010","unstructured":"Zhu F, Zhan S, Hou Q et al (2010) Booster vaccination against pertussis in Chinese children at 6\u00a0years of age using reduced antigen content diphteria-tetanus-acellular pertussis vaccine (BoostrixTM). Hum Vaccin 6:263\u2013269","journal-title":"Hum Vaccin"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1294-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-010-1294-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1294-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-010-1294-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:26:39Z","timestamp":1659057999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-010-1294-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,21]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1294"],"URL":"https:\/\/doi.org\/10.1007\/s00431-010-1294-4","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,21]]},"assertion":[{"value":"28 June 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}